Related references
Note: Only part of the references are listed.Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation
Kai Liu et al.
MEDICAL ONCOLOGY (2020)
Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis
Shai White-Gilbertson et al.
CANCER MEDICINE (2020)
Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer
Junsong Chen et al.
CURRENT CANCER DRUG TARGETS (2019)
EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment
Xinlu Wang et al.
MEDICAL ONCOLOGY (2019)
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance
Sarah R. Amend et al.
PROSTATE (2019)
The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance
Fei Fei et al.
LABORATORY INVESTIGATION (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Arlene A. Forastiere et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Endoreplication: The Good, the Bad, and the Ugly
Zhiqiang Shu et al.
TRENDS IN CELL BIOLOGY (2018)
Roles of Polyploid/Multinucleated Giant Cancer Cells in Metastasis and Disease Relapse Following Anticancer Treatment
Razmik Mirzayans et al.
CANCERS (2018)
Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells
N. Niu et al.
ONCOGENE (2017)
Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer
Karuna Mittal et al.
BRITISH JOURNAL OF CANCER (2017)
The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer
Fei Fei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
A Fraction of CD133+CNE2 Cells Is Made of Giant Cancer Cells with Morphological Evidence of Asymmetric Mitosis
Qingping Jiang et al.
JOURNAL OF CANCER (2015)
p53 Configures the G2/M arrest response of nucleostemin-deficient cells
G. Huang et al.
CELL DEATH DISCOVERY (2015)
Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor
Hongcheng Lv et al.
BMC CANCER (2014)
Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel
Shiwu Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
eIF4B, eIF4G and RNA regulate eIF4A activity in translation initiation by modulating the eIF4A conformational cycle
Ulf Harms et al.
NUCLEIC ACIDS RESEARCH (2014)
Generation of cancer stem-like cells through the formation of polyploid giant cancer cells
S. Zhang et al.
ONCOGENE (2014)
CoCl2, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics in Colon Cancer
Laura M. Lopez-Sanchez et al.
PLOS ONE (2014)
Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo
Shiwu Zhang et al.
CANCER LETTERS (2013)
Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
Xing Yao et al.
ONCOTARGETS AND THERAPY (2012)
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
Patrick W. B. Derksen et al.
CANCER CELL (2006)
Share Paper
